Table of Contents

2019-2024 Global Rydapt Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Rydapt Consumption 2014-2024
  • 2.1.2 Rydapt Consumption CAGR by Region
• 2.2 Rydapt Segment by Type
  • 2.2.1 AML
  • 2.2.2 ASM, SM-AHN, or MCL
• 2.3 Rydapt Consumption by Type
  • 2.3.1 Global Rydapt Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Rydapt Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Rydapt Sale Price by Type (2014-2019)
• 2.4 Rydapt Segment by Application
  • 2.4.1 Hospital
  • 2.4.2 Pharmacy
• 2.5 Rydapt Consumption by Application
  • 2.5.1 Global Rydapt Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Rydapt Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Rydapt Sale Price by Application (2014-2019)

3 Global Rydapt by Players

• 3.1 Global Rydapt Sales Market Share by Players
  • 3.1.1 Global Rydapt Sales by Players (2017-2019)
  • 3.1.2 Global Rydapt Sales Market Share by Players (2017-2019)
• 3.2 Global Rydapt Revenue Market Share by Players
  • 3.2.1 Global Rydapt Revenue by Players (2017-2019)
  • 3.2.2 Global Rydapt Revenue Market Share by Players (2017-2019)
• 3.3 Global Rydapt Sale Price by Players
• 3.4 Global Rydapt Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Rydapt Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Rydapt Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Rydapt by Regions

• 4.1 Rydapt by Regions
  • 4.1.1 Global Rydapt Consumption by Regions
  • 4.1.2 Global Rydapt Value by Regions
• 4.2 Americas Rydapt Consumption Growth
• 4.3 APAC Rydapt Consumption Growth
• 4.4 Europe Rydapt Consumption Growth
• 4.5 Middle East & Africa Rydapt Consumption Growth

5 Americas

• 5.1 Americas Rydapt Consumption by Countries
  • 5.1.1 Americas Rydapt Consumption by Countries (2014-2019)
  • 5.1.2 Americas Rydapt Value by Countries (2014-2019)
• 5.2 Americas Rydapt Consumption by Type
• 5.3 Americas Rydapt Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Rydapt Consumption by Countries
  • 6.1.1 APAC Rydapt Consumption by Countries (2014-2019)
  • 6.1.2 APAC Rydapt Value by Countries (2014-2019)
• 6.2 APAC Rydapt Consumption by Type
• 6.3 APAC Rydapt Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Rydapt by Countries
  • 7.1.1 Europe Rydapt Consumption by Countries (2014-2019)
  • 7.1.2 Europe Rydapt Value by Countries (2014-2019)
• 7.2 Europe Rydapt Consumption by Type
• 7.3 Europe Rydapt Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Rydapt by Countries
  • 8.1.1 Middle East & Africa Rydapt Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Rydapt Value by Countries (2014-2019)
• 8.2 Middle East & Africa Rydapt Consumption by Type
• 8.3 Middle East & Africa Rydapt Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.2 Rydapt Distributors
• 10.3 Rydapt Customer

11 Global Rydapt Market Forecast

• 11.1 Global Rydapt Consumption Forecast (2019-2024)
• 11.2 Global Rydapt Forecast by Regions
  • 11.2.1 Global Rydapt Forecast by Regions (2019-2024)
  • 11.2.2 Global Rydapt Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Rydapt Forecast by Type
• 11.8 Global Rydapt Forecast by Application

12 Key Players Analysis

• 12.1 Novartis
  • 12.1.1 Company Details
  • 12.1.2 Rydapt Product Offered
  • 12.1.3 Novartis Rydapt Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Novartis News

...

13 Research Findings and Conclusion

Rydapt is a multi-targeted protein kinase inhibitor that has been investigated for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and advanced systemic mastocytosis.
North America is the largest Sales place, with a Sales market share nearly 75.2% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 24.8%. In USA, The National Cancer Institute estimates that in 2017 approximately 21,380 people will be diagnosed with AML and 10,590 may die of the disease. About one-third of these AML patients will have a FLT3 gene mutation.

According to this study, over the next five years the Rydapt market will register a 26.8% CAGR in terms of revenue, the global market size will reach US$ 480 million by 2024, from US$ 150 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rydapt business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Rydapt market by product type, application, key manufacturers and key regions and countries.

This study considers the Rydapt value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
AML
ASM, SM-AHN, or MCL
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Rydapt consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rydapt market by identifying its various subsegments.
Focuses on the key global Rydapt manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rydapt with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rydapt submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.